ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,311
Screening encounters
1,373
Diagnostic referrals
254
Outstanding pathways
131

Screening pathway

  1. Screening1,373Encounters
  2. Positive finding458Documented findings
  3. Referral254Diagnostic referrals
  4. Follow-up272Diagnostic visits
  5. Outcome123Resolved pathways

Stage totals use different units. Pending pathways: 131. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0652 · EXP-0652Synthetic · Site A

Full participant history through 2025-08-29, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-08-17
  4. · Diagnostic referral · EXP-0652-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Contact difficulty
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Navigation intervention · Coordination support
  12. · Diagnostic visit · Attended
  13. · Diagnosis · Colposcopy · Biopsy collected
  14. · Diagnosis · Histopathology · No high-grade lesion identified
  15. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-05-05
  16. · Follow-up disposition · Resolved · EXP-0652-T-R
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

1311 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0203 · Expanded synthetic participant 0203Site D — Community Engagement Programme
EXP-0206 · Expanded synthetic participant 0206Site D — Community Engagement Programme
EXP-0210 · Expanded synthetic participant 0210Site E — Resource-Constrained Navigation Programme
EXP-0211 · Expanded synthetic participant 0211Site E — Resource-Constrained Navigation Programme
EXP-0213 · Expanded synthetic participant 0213Site E — Resource-Constrained Navigation Programme
EXP-0214 · Expanded synthetic participant 0214Site E — Resource-Constrained Navigation Programme
EXP-0218 · Expanded synthetic participant 0218Site B — Peri-Urban Access Programme
EXP-0219 · Expanded synthetic participant 0219Site C — Rural Outreach Programme
EXP-0222 · Expanded synthetic participant 0222Site D — Community Engagement Programme
EXP-0230 · Expanded synthetic participant 0230Site B — Peri-Urban Access Programme
EXP-0233 · Expanded synthetic participant 0233Site C — Rural Outreach Programme
EXP-0239 · Expanded synthetic participant 0239Site A — Urban Referral Hub
EXP-0247 · Expanded synthetic participant 0247Site C — Rural Outreach Programme
EXP-0249 · Expanded synthetic participant 0249Site E — Resource-Constrained Navigation Programme
EXP-0253 · Expanded synthetic participant 0253Site D — Community Engagement Programme
EXP-0256 · Expanded synthetic participant 0256Site A — Urban Referral Hub
EXP-0258 · Expanded synthetic participant 0258Site A — Urban Referral Hub
EXP-0265 · Expanded synthetic participant 0265Site C — Rural Outreach Programme
EXP-0267 · Expanded synthetic participant 0267Site A — Urban Referral Hub
EXP-0271 · Expanded synthetic participant 0271Site B — Peri-Urban Access Programme
EXP-0273 · Expanded synthetic participant 0273Site C — Rural Outreach Programme
EXP-0277 · Expanded synthetic participant 0277Site C — Rural Outreach Programme
EXP-0281 · Expanded synthetic participant 0281Site A — Urban Referral Hub
EXP-0282 · Expanded synthetic participant 0282Site E — Resource-Constrained Navigation Programme
EXP-0285 · Expanded synthetic participant 0285Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
592
HPV DNA
587
Cytology
194

Navigation activity

Barrier documented
201
Contact attempt
375
Navigation intervention
85
Diagnostic booking
309
Diagnostic visit
272

Documented barriers

Contact difficulty
64
Transport difficulty
64
Appointment coordination
73

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.